Secondary hyperparathyroidism (SHPT) is one of the most common abnormalities of mineral metabolism in patients with chronic kidney disease (CKD), and is characterized by hyperplasia of the parathyroid glands and increased plasma levels of parathyroid hormone (PTH) [1]. This evidence concerns the gene PTH and secondary hyperparathyroidism.